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Submitted 1 June 2011; accepted 22 June 2011Abstract Introduction: The treatment options for an infected fenestrated endovascular
aneurysm repair (FEVAR) are limited.
Report: A patient with a bi-renal FEVAR developed a type 1a and type 3 endoleak, with
destruction of the neck of the aneurysm, likely due to infection. In a tapered thoracic aortic
stent, “home-made” fenestrations were created for the renal arteries and superior mesenteric
artery. Successful coverage of the infected aorta excluded the endoleaks. Life-long antibiotics
were commenced.
Discussion: There was a risk of imminent rupture, thus ruling out waiting for a custom-made
FEVAR. This technique facilitated emergent treatment, and obviated the need for open
surgery.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.Introduction
Aortic endograft (EVAR) infection is a catastrophic compli-
cation with significant morbidity and mortality.1 The
natural history without treatment is rapid aorticDOI of original article: 10.1016/j.ejvs.2011.07.001.
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doi:10.1016/j.ejvsextra.2011.06.007destruction and subsequent rupture. Clinical signs and
symptoms include fevers, abdominal pain, sepsis syndrome
and septic embolisation.2 Treatment options for infected
endografts are limited and are invariably associated with
significant morbidity and mortality. We report a case of an
infected fenestrated endograft (FEVAR) with large type 1a
and 3 endoleaks successfully treated with a “home-made”
fenestrated cuff.
Report
A 64 year old man with a history of ischaemic heart disease
and stage 5 chronic kidney disease underwent FEVAR, withElsevier Ltd. Open access under CC BY-NC-ND license.
The Use of an Endovascular Stent Graft e35fenestrations for both renal arteries and a scallop for the
superior mesenteric artery (SMA). 6 months post-procedure
he presented with a persistent fever. Blood tests showed
raised inflammatory markers, although blood cultures were
persistently sterile. Computed tomographic angiography
(CTA) demonstrated a new type 1a endoleak arising from
the SMA scallop, and a type 3 endoleak arising from the
right renal artery fenestration (Fig. 1a). Though a repeat
CTA 4 weeks later demonstrated the aneurysm sac
remained stable in size, there were now more prominent
endoleaks and a loss of definition of the posterior wall of
the aorta particularly at the neck (Fig. 1b). A positron
emission tomography CT scan showed areas of high fluo-
rodeoxyglucose avidity at the proximal end of the endograft
(Fig. 1c), leading to the diagnosis of infective aortitis. He
was commenced on empirical broad spectrum antibiotics
intravenously for one week prior to intervention; this lead
to normalisation of his serum inflammatory markers.
The patient was considered high risk for open surgery,
given his medical co-morbidities, anatomical challenge
with an endograft in-situ and the inflamed, infected aorta.
Endovascular options were therefore considered.
In order to exclude the endoleak, the endograft seal
needed to extend to healthy proximal aorta; above the
coeliac axis. The minimum time required for manufacturing
a custom-made Zenith (Cook Medical, Perth, Australia)
fenestrated endograft is six weeks and the clinical
presentation made it unsafe to wait this long. Therefore
the option of home-made fenestrations in a thoracic
endograft was discussed with the patient and appropriate
consent obtained.
A 36-32mm tapered TX2 thoracic endograft (Cook
Medical, Perth, Australia) was unsheathed ex-vivo under
sterile conditions on the operating theatre sidetable.
Fenestrations were created into the graft using cautery
(Fig. 2a), in positions marked for the renal arteries and SMA
as planned (TeraRecon, Houston, Texas). The visceral
anatomy allowed for the coeliac artery to be sacrificed. The
fenestrations were reinforced using nitinol rings and radio-
opaque markers were sutured onto the fabric (Fig. 2b). The
endograft was shortened to appropriate length and diam-
eter reducing ties placed. The graft was then re-sheathed
and imaged to confirm orientation and ease of identifica-
tion of markers.
The new graft was trans-femorally uploaded through the
existing endograft, positioned under fluoroscopy and
deployed into the patient in the usual fashion. 6  22 mmFigure 1 (a) Reformatted CT angiogram showing a type 1a end
endoleak (thin arrow) arising from the right renal artery fenestrati
posterior wall of the aorta (dotted arrows). (c) PET CT image showin
and endograft (thick arrow).covered stents (Atrium Medical, Hudson, USA) were
deployed through existing renal stents into the renal
arteries and a 7  38 mm covered stent was used for the
SMA.
CTA performed 2 weeks following the operation showed
patent target vessels and exclusion of the aneurysm
(Fig. 2c). The patient remains on a life long empirical broad
spectrum oral antibiotic He was well with normal serum
inflammatory markers at one month follow-up, and is due
for review with a repeat CT at six months post-operation.Discussion
It is generally accepted that for infections of surgical
grafts, antibiotics alone will not suffice, though success
with this approach for EVAR has been reported.1 Graft or
endograft explantation followed by in-situ replacement
with antibitiotic soaked dacron or oversewing of the aortic
stump with extra-anatomic bypass are amongst the recog-
nised options, though both are associated with significant
morbidity and mortality.3 If the infected graft or endograft
includes the visceral vessels, the complexity increases as
visceral revascularisation must also be performed.
The current case describes an aortitis presumably
infectious in origin. It is unclear whether the patient had
any risk factors for endograft infection prior to his initial
FEVAR; he had no known episodes of septicaemia which
may have lead to mycotic aneurysm formation, and he had
been well peri-operatively.
Loss of the proximal seal as evidenced by the emergence
of a type 1a endoleak suggests he was at imminent risk of
rupture, precluding conservative management.
Whilst outside the instructions for use for Cook Zenith
endografts, the creation of “home-made” fenestrations has
been described and facilitates complex endovascular repair
in urgent settings.4
Careful planning is essential, in order to mark the posi-
tions for the fenestrations, and the use of multi-planar
reformatting and centerline analysis of the CTA using
a workstation such as TeraRecon (TeraRecon, Houston,
Texas) is invaluable.
Long term outcome for this patient is unclear and life-
long surveillence will be required. The nidus of infection,
presumably the initial endograft, is still present and
consequently despite life long antibiotics, the infection
may propagate and affect the new graft. Reports regardingoleak (thick arrow) arising from the SMA scallop and a type 3
on. (b) Reformatted CT angiogram. Note the destruction of the
g an area of avid FDG uptake centered around the aneurysm sac
Figure 2 (a) Intra-operative picture showing the creation of a fenestration into the graft (thick arrow) using cautery (thin arrow).
(b) Intra-operative picture showing the fenestrations re-enforced with nitinol rings (thick arrow) and sutured radio-opaque markers
(thin arrow). (c) Reformatted CT angiogram 2 weeks post-procedure, showing good graft position, patent target vessels and no
endoleak.
e36 L. Morgan-Rowe et al.the use of EVAR for mycotic aneurysms are promising,
however, providing some hope that this may be a durable
result for this patient.5
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